eFoodSafety.com, Inc. Reports "Significant and Unique" Bird Flu Virus Testing by the Company

Business Wire, Nov 3, 2006

Testing is Being Conducted on the Actual H5N1 Strain of the Bird Flu Virus

SCOTTSDALE, Ariz. -- eFoodSafety.com, Inc. (OTCBB:EFSF), a Company dedicated to improving health conditions around the world through innovative products and technologies, today provided additional information regarding yesterday's announcement to shareholders and the investment community about the testing of Citroxin against the Bird Flu virus at Innova Biotechnology Co., Ltd. (http://www.innovabiotechnology.com) in Thailand. This testing is especially significant because it is being conducted on the actual H5N1 strain of the Bird Flu virus, not the surrogate H9N2 strain that most domestic laboratories are currently using in their Bird Flu testing. Citroxin can be sprayed on bird cages and hen houses without it being harmful to animals or humans in surrounding areas if ingested.

The Company has taken the time to locate a facility that has the actual H5N1 Bird Flu virus that has killed millions of birds in Asia and the actual strain that has led to human deaths. The significance of eFoodSafety's groundwork testing to date will allow the Company to report results taken against the exact H5N1 virus, the viral strain that has killed millions of birds and some humans over the past several years.

The Company is also closely monitoring the H5N1 virus because indications are that a mutated strain of Bird Flu virus, a "Fujian-like strain," has emerged in response to vaccination programs designed to halt the disease in farm flocks. Indications are that this strain has emerged abroad, but not domestically yet.

Patricia Gruden, President and CEO of eFoodSafety.com, Inc., stated, "Experts continue to renew their warnings of a Bird Flu pandemic and the World Health Organization continues to express its fear that a Bird Flu pandemic could kill millions in a worst case scenario. For that reason, testing with Citroxin is significant and unique in that we are at the forefront of testing on the exact and specific H5N1 strain of the Bird Flu virus that has been found to be the cause of human deaths."

Mrs. Gruden further observed, "Having established clearly defined testing protocol guidelines on testing of the actual H5N1 Bird Flu virus enables eFoodSafety to be at the forefront of testing, with the next level of testing on live subjects already in place. The Company's Citroxin formulation represents one of the products we are developing as we continue to work toward our ultimate goal of becoming a provider of global healthcare technologies."

About eFoodSafety.com, Inc.

eFoodSafety.com, Inc. is dedicated to improving health conditions around the world through its innovative technologies. The company's Knock-Out Technologies, Ltd. subsidiary has developed an environmentally safe sporicidal product formulated entirely of food-grade components that eradicates anthrax and a germicidal product, Citroxin (formerly named Big Six Plus) - EPA Reg. No. 82723-1 that kills six major bacteria: E-coli, Listeria, Pseudomonas, Salmonella, Staphylococcus, and Streptococcus, Avian Influenza, Black Mold. The sporicidal product has completed its final efficacy laboratory study requisite for EPA registration. In the study, it eradicated both Clostridium Sporogenes and Bacillus Subtilis with 100% efficacy on both hard and porous surfaces. The company's MedElite, Inc. subsidiary distributes clinically proven products to physicians who then prescribe the products for their patients. It recently became the owner of the Talsyn[TM]-CI/bid Scar Cream, that has been clinically proven to facilitate and improve the appearance, redness and strength of scars (www.talsyn.com), as well as seven (7) other products in the Talsyn[TM] line. The company is also is a distributor for Cinnergen[TM], a non-prescription liquid whole food nutritional supplement that promotes healthy glucose metabolism (www.cinnergen.com), and Trimmendous[TM], a weight loss formula focusing on the body's 24-hour metabolic processes. The company has recently entered into a joint venture agreement with CK41 Direct, Inc. to launch an anti-acne skin care system, with a branded name and celebrity spokesperson to be announced in the near future.

Please visit the Company's website at: http://www.efoodsafety.com.

Safe Harbor Forward-Looking Statements

Statements contained in this release that are not strictly historical are "forward-looking" statements within the meaning of Section 27A of the Securities Act of 1933 as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. The forward-looking statements are made based on information available as of the date hereof, and the company assumes no obligation to update such forward-looking statements. Editors and investors are cautioned that such forward-looking statements involve risks and uncertainties and the company's actual results may differ from these forward-looking statements. Such risks and uncertainties include but are not limited to demand for the company's products and services, our ability to continue to develop markets, general economic conditions, our ability to secure additional financing for the company and other factors that may be more fully described in reports to shareholders and periodic filings with the Securities and Exchange Commission.